Fresenius Medical Care promotes Joe Turk to head of renal therapies
Click Here to Manage Email Alerts
Fresenius Medical Care North America has promoted Joe Turk, previously the head of Home and Critical Care Therapies, to president of the company’s Renal Therapies Group.
In his new role, Turk will oversee renal products and pharmaceutical operations, including sales, clinical support, product marketing and management, customer and technical services and regulatory affairs.
The company said Turk’s appointment will align the company’s products teams into one organization – with a focus on efficiently and effectively delivering new technologies.
“Joe’s decades of strategy and market development experience have been critical in expanding our footprint and technologies in home dialysis and critical care since he joined us as part of the NxStage merger in 2019,” Bill Valle, CEO of FMCNA, said in a press release. “Joe’s leadership will be instrumental as we focus on better leveraging best practices across divisions for the benefit of our customers, partners, field teams and most importantly our patients.”
Turk succeeds Mark Costanzo, who recently retired as president of FMCNA's Renal Therapies Group.
“I am thrilled to bring our exceptional teams together at this important time,” Turk said. “We have an incredible opportunity as the market leader to work together to ensure we’re providing the highest quality care and renal products to the patients we are privileged to serve.”
Read more about
Click Here to Manage Email Alerts